Description The present invention relates to new application forms of synthetic BPC (Body Protection Compound) peptides comprising 8 to 15 amino acid residues with a molecular weight of 900 to 1,600 daltons, which have organo-protective activity, to processes for their preparation and their use in diagnosis and therapy
The lyophilisation process removes water content to below 3%, which eliminates hydrolytic degradationthe primary pathway through which peptide bonds break down at ambient temperatures
Methyl Max Injections Each 1 ml contains 5000 mcg of methylcobalamin
antimutagenic effects in lymphocytes Each of these domains plays a foundational role in biological aging, and Epitalons ability to modulate them suggests its legitimate potential as a systemic geroprotector
It is a clinical discipline
For post-illness recovery, some protocols include Thymosin Alpha-1 for immune support